Cigna Group (NYSE:CI) Stock Rating Lowered by Wall Street Zen

Cigna Group (NYSE:CIGet Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.

Other equities analysts have also recently issued reports about the company. Morgan Stanley restated an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a research note on Friday, October 31st. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Cantor Fitzgerald decreased their price target on shares of Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st. Robert W. Baird dropped their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Finally, Leerink Partners cut their target price on shares of Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $330.36.

Check Out Our Latest Report on Cigna Group

Cigna Group Stock Down 0.4%

NYSE:CI opened at $279.31 on Friday. The company has a market capitalization of $74.61 billion, a price-to-earnings ratio of 12.32, a price-to-earnings-growth ratio of 0.99 and a beta of 0.26. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The stock has a 50-day simple moving average of $274.46 and a 200 day simple moving average of $285.81. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter in the prior year, the firm posted $7.51 earnings per share. Cigna Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Insider Activity at Cigna Group

In other news, CEO David Cordani acquired 4,134 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Cigna Group

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Harbor Capital Advisors Inc. boosted its holdings in shares of Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares during the period. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group in the 4th quarter valued at approximately $28,000. Solstein Capital LLC acquired a new position in Cigna Group in the 2nd quarter worth approximately $29,000. Chilton Capital Management LLC purchased a new position in Cigna Group during the 2nd quarter worth approximately $30,000. Finally, Princeton Global Asset Management LLC raised its stake in Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 52 shares during the period. 86.99% of the stock is currently owned by institutional investors.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.